Clopidogrel is a recently developed thrombocyte inhibitor with fewer side e
ffects. We report 2 patients with purpura and thrombopenia, respectively, d
ue to clopidogrel therapy. As this compound is widely used in clinical prac
tice, the occurrence of hematological and dermal side effects should be con
sidered. Copyright(C) 2001 S. Karger AG, Basel.